Several medical and orthopedic device company stocks recovered after suffering significant losses at the end of last week, perhaps due to a Center for Medicare and Medicaid Services announcement that it would conduct checks before authorizing select treatment in the United States prone to high levels of improper payment, according to a report from Financial Times.
Spine device company NuVasive stocks increased by 13.3 percent, while Medtronic stocks increased by 4 percent after seeing a big decrease at Friday's opening price. Despite the recovery, analysts are still worried that the announcement will limit access to orthopedic and spine care.
Currently, there are 11 states involved in the pilot program that will begin the pre-audit for procedure coverage.
Over the past week, Stryker, Zimmer Holdings, Smith & Nephew and Medtronic stock prices have all significantly increased. Smith & Nephew experienced the highest increase in opening prices for today versus last Tuesday, seeing a $2.73 rise to $46.45 today. Stryker was a close second, increasing by $2.23 to $49.23 today.
Related Articles on Orthopedic Surgery:
8 Points on Knee Arthroscopy in Surgery Centers
ACL Reconstruction Technique Has Good Outcomes After 13 Years
Dr. Michael Bronson Performs Anterior Hip Replacement at Mount Sinai Medical Center
Currently, there are 11 states involved in the pilot program that will begin the pre-audit for procedure coverage.
Over the past week, Stryker, Zimmer Holdings, Smith & Nephew and Medtronic stock prices have all significantly increased. Smith & Nephew experienced the highest increase in opening prices for today versus last Tuesday, seeing a $2.73 rise to $46.45 today. Stryker was a close second, increasing by $2.23 to $49.23 today.
Related Articles on Orthopedic Surgery:
8 Points on Knee Arthroscopy in Surgery Centers
ACL Reconstruction Technique Has Good Outcomes After 13 Years
Dr. Michael Bronson Performs Anterior Hip Replacement at Mount Sinai Medical Center